The SYNGAP1 gene, which supports the production of a protein called SynGAP (Synaptic Ras GTPase-Activating Protein), is known to play a key role in supporting the development of synapses and neural ...

The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in ...

CURE SYNGAP1 501(c)(3) is pleased to announce a $130,000 grant to Dr. Helen Willsey and Dr. David Kastner at the University of California, San Francisco (UCSF). This funding extends Dr. Willsey's ...

SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment, causing epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It is caused by mutations in ...

Mill Valley, CA – April 15, 2026 – CURE SYNGAP1, the premier global patient advocacy group dedicated to transforming the lives of those living with SYNGAP1-Related Disorders (SRD), today announced ...

CAMP4 Therapeutics reports promising results for CMP-SYNGAP-01 and CMP-CPS-001 in treating genetic disorders, with favorable safety data. CAMP4 Therapeutics announced promising results from its ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In early January 2014, my wife and I drove to the hospital in ...

The SYNGAP1 gene provides instructions for making a protein called SynGAP, which plays an essential role in nerve cells in the brain. SYNGAP1 mutations' prevalence is 2%-4% of sporadic (non-Inherited) ...

Mill Valley, CA — May 19th 2026 — CURE SYNGAP1 is proud to announce a strategic investment of $111,960 in RARE-X to accelerate the collection of high-quality Patient-Reported Outcome measures (PROs) ...

57 hours and 56 minutes. That's how long it took three dads to drive across the country to raise money for their sons' rare genetic disease. Last week, Brett Stelmaszek, Kevin Frye and Peter ...